Barclays’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-486,514
Closed -$44.5M 7173
2019
Q3
$44.5M Buy
486,514
+268,208
+123% +$24.5M 0.03% 510
2019
Q2
$19.8M Buy
218,306
+195,524
+858% +$17.2M 0.01% 941
2019
Q1
$1.67M Sell
22,782
-16,503
-42% -$1.19M ﹤0.01% 2774
2018
Q4
$2.65M Sell
39,285
-25,922
-40% -$1.83M ﹤0.01% 2124
2018
Q3
$4.78M Buy
65,207
+34,141
+110% +$2.73M ﹤0.01% 1864
2018
Q2
$2.5M Sell
31,066
-27,150
-47% -$2.04M ﹤0.01% 2355
2018
Q1
$3.66M Buy
58,216
+11,163
+24% +$743K ﹤0.01% 1880
2017
Q4
$2.98M Buy
47,053
+35,958
+324% +$2.56M ﹤0.01% 2071
2017
Q3
$866K Buy
11,095
+3,280
+42% +$250K ﹤0.01% 3136
2017
Q2
$611K Buy
7,815
+6,419
+460% +$447K ﹤0.01% 3326
2017
Q1
$81K Sell
1,396
-6,603
-83% -$357K ﹤0.01% 5044
2016
Q4
$397K Sell
7,999
-27,731
-78% -$1.44M ﹤0.01% 3595
2016
Q3
$1.99M Buy
35,730
+24,253
+211% +$1.29M ﹤0.01% 2007
2016
Q2
$538K Buy
11,477
+5,803
+102% +$253K ﹤0.01% 3147
2016
Q1
$215K Buy
5,674
+1,682
+42% +$65.4K ﹤0.01% 3796
2015
Q4
$196K Sell
3,992
-3,927
-50% -$173K ﹤0.01% 3917
2015
Q3
$333K Sell
7,919
-16,538
-68% -$840K ﹤0.01% 3709
2015
Q2
$1.32M Buy
24,457
+22,834
+1,407% +$1.23M ﹤0.01% 2627
2015
Q1
$80K Sell
1,623
-1,507
-48% -$69.8K ﹤0.01% 4984
2014
Q4
$147K Buy
3,130
+1,261
+67% +$54.6K ﹤0.01% 4886
2014
Q3
$83K Buy
1,869
+217
+13% +$9.61K ﹤0.01% 5479
2014
Q2
$69K Sell
1,652
-9,311
-85% -$387K ﹤0.01% 5734
2014
Q1
$592K Buy
10,963
+3,315
+43% +$202K ﹤0.01% 3786
2013
Q4
$458K Sell
7,648
-29,444
-79% -$1.63M ﹤0.01% 4183
2013
Q3
$1.82M Buy
37,092
+3,582
+11% +$158K ﹤0.01% 2694
2013
Q2
$1.3M Buy
+33,510
New +$1.09M ﹤0.01% 3050

Other funds holding MDSO

Barclays's MDSO Position: Q4 2019 in Review

Barclays sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 486,514 shares — an estimated $44.5M sold.

Barclays first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $44.5M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • Barclays reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • Barclays sold 486,514 Medidata Solutions, Inc. shares in Q4 2019, an estimated $44.5M.
  • Barclays first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
  • Barclays's Medidata Solutions, Inc. position peaked at $44.5M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.